Health Care · Pharmaceutical Preparations · Nasdaq · CIK 275053 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $20.57Day −0.82%Mkt cap $362MP/E (FY) 19.4×1Y +40.4%Off 52W high −26.9%Vol (1Y) 48.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 4,296 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest2.9% of sh out |
| Days to cover5.1d |
| 13F net flow (QoQ)+4.34% |
| Top-10 13F concentration63.0% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)19.4× |
| Sales (TTM)$489.8M |
| Earnings (TTM)$19.9M |
| Net margin4.1% |
| ROIC23.6% |
| Sales growth 3Y4.4% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−4.7% |
| 1Y+40.4% |
| 3Y+47.5% |
| 5Y+18.8% |
| 10Y+88.6% |
| Since incept. (ann.)+13.9% |
Total return through 2026-07-29 · series begins 2009-06-25. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)48.0% |
| Ann. volatility (3Y)45.4% |
| Sharpe (1Y)0.93 |
| Sharpe (3Y)0.50 |
| Max drawdown (1Y)−29.2% |
| Max drawdown (3Y)−45.7% |
| Beta (3Y vs SPY)0.49 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC | 2.5M | $59M | 14.07% | +0.0% |
| Prescott Group Capital Management, L.L.C. | 1.8M | $43M | 10.14% | +0.0% |
| BlackRock, Inc. | 1.1M | $26M | 6.05% | −5.0% |
| DIMENSIONAL FUND ADVISORS LP | 895,437 | $21M | 5.09% | −0.1% |
| KENNEDY CAPITAL MANAGEMENT LLC | 691,498 | $17M | 3.93% | +2.4% |
| ACADIAN ASSET MANAGEMENT LLC | 657,805 | $16M | 3.74% | +4.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 596,833 | $14M | 3.39% | new |
| AMERICAN CENTURY COMPANIES INC | 574,825 | $14M | 3.27% | +26.3% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | $0.29 | +16.0% | $122.9M | +8.5% |
| 2025-12-31 | 2026-03-10 | — | — | $123.8M | +4.7% |
| 2025-09-30 | 2025-11-06 | $0.30 | +30.4% | $128.3M | +12.0% |
| 2025-06-30 | 2025-07-31 | $0.28 | +300.0% | $114.8M | +3.8% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Other Countries 36% · US 28% · TW 14% · JP 12% · KR 11%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
